|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-3.41/-0.74
|
企業價值
10.72M
|
資產負債 |
每股賬面淨值
1.68
|
現金流量 |
現金流量率
--
|
損益表 |
收益
310.00K
|
每股收益
0.00
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/20 14:45 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatmentand potentially enable fast-track therapeutic development in this patient population. |